HSV-tk/IL-2 Gene Therapy for Glioblastoma Multiforme
关键词: gene therapy glioblastoma来源: 互联网
We performed a clinical trial of gene therapy in patients with recurrent glioblastoma multiforme based on retroviral vector-mediated combined delivery of interleukin-2 and thymidine kinase of herpes simplex virus (HSV)-1. Treatment consisted of intratumor injection of retroviral vector-producing cells, followed by intravenous ganciclovir administration. The primary endpoints of the study were the evaluation of the safety of the treatment and demonstration of transduction of tumor cells. Here, we report details on the clinical protocol and the methods used.
推荐方法
- Differential Staining Cytotoxicity Assay: A Review
- Anti-HMdU Autoantibodies in Human Sera as a Biomarker of Cancer Risk
- Pooled ShRNA Screenings: Computational Analysis
- Immunocytochemical Detection and Characterization of Individual Micrometastatic Tumor Cells
- Measurement of Estrogen Receptor Status by Immunocytochemistry in Paraffin Wax Sections
- Genetic Modification of Cell Lines to Enhance Their Metastatic Capability
- Polymeric Micelles: Polyethylene Glycol-Phosphatidylethanolamine (PEG-PE)-Based Micelles as an Example
- Markers of Tumor Burden: An Overview
- Photodynamic Therapy in Lung Cancer: A Review
- 诱导多能干细胞